发明名称 COMPOUNDS FOR TREATING PATIENTS WITH ROS1 MUTANT CANCER CELLS.
摘要 Substituted indazole derivatives of formula (I) or formula 2.(I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.
申请公布号 MX2016010519(A) 申请公布日期 2016.11.16
申请号 MX20160010519 申请日期 2015.02.19
申请人 IGNYTA, INC. 发明人 Jonathan LIM;Elena ARDINA;Maria MENICHINCHERI
分类号 A61K31/496;A61P35/04 主分类号 A61K31/496
代理机构 代理人
主权项
地址